• No results found

For the purpose of transacting the business set out below

N/A
N/A
Protected

Academic year: 2021

Share "For the purpose of transacting the business set out below"

Copied!
7
0
0

Loading.... (view fulltext now)

Full text

(1)

A Meeting of the Trust Board of Directors, in Public

To be held on Friday 29

th

April 2016, starting at 2.00 pm

in the West Arch Boardroom, Diana Princess of Wales Hospital

For the purpose of transacting the business set out below

1. Apologies for Absence Verbal

Dr James Whittingham, Chairman

2. Chairman’s Remarks Verbal

Dr James Whittingham, Chairman

3. Declaration of Interests Verbal

Dr James Whittingham, Chairman

4. To Approve the Minutes of the Previous Meeting held on 29th March 2016 To Follow

Dr James Whittingham, Chairman NLG(16)151

5. Matters Arising from the Minutes:

5.1 Update on Actions from Governance Time-Out held on 5th February To Follow

2016 (5 mins) NLG(16)152

Wendy Booth, Director of Performance Assurance & Trust Secretary & Jayne Adamson, Interim HR Adviser

6. Chief Executive’s Monthly Update for April 2016 (20 mins) To Follow

Karen Jackson, Chief Executive NLG(16)153

7. Quality and Safety:

7.1 Patient Story – (TBC) (5 mins) Verbal

Jo Loughborough, Patient Experience Practitioner

7.2 Quality Development and Continuous Improvement Plans:

7.2.1 Publication of CQC Inspection Visit Report & Next Steps (10 mins) To Follow Wendy Booth, Director of Performance Assurance & Trust Secretary NLG(16)154

7.2.2 Quality Development Plan and KPI’s (5 mins) To Follow Wendy Booth, Director of Performance Assurance & Trust Secretary NLG(16)155

7.3 Serious Untoward Incidents including ‘Never Events’ (5 mins) To Follow Wendy Booth, Director of Performance Assurance & Trust NLG(16)156

(2)

7.4 Staffing Reports:

7.4.1 Staffing Capacity and Capability on our Wards (5 mins) To Follow

Tara Filby, Chief Nurse NLG(16)157

7.5 National Staff Survey (5 mins) To Follow

Dr Karen Dunderdale, Deputy Chief Executive NLG(16)158

7.6 Draft Annual Quality Account for 2015/16 & Arrangements for Approval of To Follow

the Final Document/Delegation of Authority to QPEC (5 mins) NLG(16)159 Wendy Booth, Director of Performance Assurance & Trust Secretary

& Tara Filby, Chief Nurse Reports from Board Sub Committees:

7.8 Quality and Patient Experience Committee (QPEC):

7.8.1 QPEC Highlight Report, April 2016 (5 mins) To Follow

Alan Bell, Non-Executive Director NLG(16)160

7.8.2 Board Challenge Verbal

7.9 Mortality Performance & Assurance Committee (MPAC):

7.9.1 Mortality Performance Assurance Committee Highlight Report, To Follow

April 2016 (5 mins) NLG(16)161

Dr James Whittingham, Chairman

7.9.2 Board Challenge Verbal

7.10 Infection Prevention & Control Committee (IPCC):

7.10.1 IPCC Highlight Report, April 2016 (5 mins) To Follow

Stan Shreeve, Non-Executive Director NLG(16)162

7.10.2 Board Challenge

7.11 Reflection on a Patient Story (10 mins) Verbal

8. Strategy and Planning:

8.1 Healthy Lives, Healthy Futures Update (10 mins) Verbal Karen Jackson, Chief Executive

8.2 Update on Changes to Trust Board Meetings & Board Sub-Committees To Follow Dr James Whittingham, Chairman & Wendy Booth, Director of Performance NLG(16)163

(3)

9. Compliance Monitoring:

Reports from Board Sub Committees:

9.1 Resources Committee:

9.1.1 Resources Committee Highlight Report, April 2016 (5 mins) To Follow

Neil Gammon, Non-Executive Director NLG(16)164

9.1.2 Approval on Finalisation of 2016/17 Sustainability Plan (5 mins) To Follow Wendy Booth, Director of Performance Assurance & Trust Secretary NLG(16)165 & Marcus Hassall, Director of Finance

9.1.3 Monitor Quarterly Compliance Report – Q4 (10 mins) To Follow Marcus Hassall, Director of Finance & Wendy Booth, Director of NLG(16)166 Performance Assurance & Trust Secretary

9.1.4 Month 12 Finance Approval & 2016/17 Plan Position To Follow

Marcus Hassall, Director of Finance NLG(16)167

9.1.5 Board Challenge Verbal

9.2 Trust Governance and Assurance Committee (TGAC):

9.2.1 TGAC Highlight Report, April 2016 (5 mins) To Follow

Anne Shaw, Non-Executive Director NLG(16)168

9.2.2 Integrated Performance/KPI Framework (5 mins) To Follow Wendy Booth, Director of Performance Assurance & Trust Secretary NLG(16)169

9.2.3 Performance Compliance Report (5 mins) To Follow Wendy Booth, Director of Performance Assurance & Trust Secretary NLG(16)170 & Karen Griffiths, Chief Operating Officer

9.2.2 Board Challenge Verbal

9.3 Audit Committee:

9.3.1 Audit Committee Highlight Report, April 2016 (5 mins) To Follow

Stan Shreeve, Non-Executive Director NLG(16)171

9.3.2 Board Challenge 9.4 Charitable Funds:

9.4.1 Charitable Funds Highlight Report, April 2016 To Follow

(4)

9.4.2 Board Challenge 10. Items for Approval

10.1 Workforce Staffing Indicator Priorities 2016/17 (5 mins) To Follow

Dr Karen Dunderdale, Deputy Chief Executive NLG(16)173

10.2 Going Concern – Annual Accounts 2015/16 (15 mins) To Follow

Marcus Hassall, Director of Finance NLG(16)174

10.3 Annual Security Management Report 2015/16 (5 mins) To Follow Wendy Booth, Director of Performance Assurance & Trust Secretary NLG(16)175

11. Matters to be Included in the Board Briefing for Governors (5 mins) Verbal Dr James Whittingham, Chairman

12. Trust Board Action Log – Public (5 mins) To Follow

Dr James Whittingham, Chairman NLG(16)176

13. Items for Information (5 mins) Please see

Dr James Whittingham, Chairman Appendix A

14. Any Other Business Verbal

15. Date and Time of the Next Meeting Verbal

The next meeting will be held on Tuesday 31st May 2016, in the Main Boardroom, Diana Princess of Wales Hospital – start time to be confirmed.

Note: Members of the public and other stakeholders are asked to note that, whilst meetings of the Trust Board are now held

in public, the primary purpose of these meetings is to enable the Trust Board to properly discharge its responsibility and conduct the business of the Trust. The meetings of the Council of Governors is the forum where the Trust Board is held to

account and is also therefore the forum where members of the public may attend to ask questions of the Trust Board. The meeting is expected to close at 5.00 pm.

(5)

PROTOCOL FOR CONDUCT OF BOARD BUSINESS

 In accordance with Standing Order 14.2 (2007), any Director wishing to propose an agenda item should send to follow notice 8 clear days before the meeting to the Chairman, who shall then include this item on the agenda for the meeting. Requests made less than 8 days before a meeting may be included on the agenda at the discretion of the Chairman. Divisional Directors and Managers may also submit agenda items in this way.

 In accordance with Standing Order 14.3 (2007), urgent business may be raised provided the Director wishing to raise such business has given notice to the Chief Executive not later than the day preceding the meeting or in exceptional circumstances not later than one hour before the meeting.

 Board members wishing to ask any questions relating to those reports listed under ‘Items for Information’ should raise them with the appropriate Director outside of the Board meeting. If, after speaking to that Director, it is felt that an issue needs to be raised in the Board setting, the appropriate Director should be given advance notice of this intention, in order to enable him/her to arrange for any necessary attendance at the meeting.

NB: When staff attend Board meetings to make presentations (having been advised of the time to arrive by the Board Secretary), it is intended to take their item next after completion of the item then being considered. This will avoid keeping such people waiting for long periods.

A P P E N D I X A

Listed below is a schedule of documents circulated to all Board members for information.

The Board has previously agreed these items do not routinely need to feature for discussion on Board agendas but that any questions arising from these papers should be raised with the responsible Director. If after having done so any Director believes there are matters arising from these documents that warrant discussion within the Board setting, they should contact the Chairman, Chief Executive or Board Administrator, who will include the issue on a future agenda.

13. Items for Information: (To note)

Sub-Committee Supporting Papers QPEC

13.1 QPEC Minutes, April 2016 To Follow

Tara Filby, Chief Nurse NLG(16)177

13.2 Monthly Quality Report, April 2016 To Follow

Tara Filby, Chief Nurse NLG(16)178

13.3 Chief Nurse Assurance Report, April 2016 To Follow

Tara Filby, Chief Nurse NLG(16)179

13.4 Quality Matrons’ Environment Report To Follow

Tara Filby, Chief Nurse NLG(16)180

13.5 National Inpatients Survey & Action Plan To Follow

Tara Filby, Chief Nurse NLG(16)181

13.6 Quarterly Nursing Update Report To Follow

(6)

MPAC

13.4 MPAC Minutes, March 2016 To Follow

Lawrence Roberts, Medical Director NLG(16)183

13.5 Monthly Mortality Report, April 2016 To Follow

Lawrence Roberts, Medical Director NLG(16)184

Resources Committee

13.6 Resources Committee Minutes, March 2016 To Follow

Dr Karen Dunderdale, Deputy Chief Executive NLG(16)185

13.7 2015/16 Sustainability Plan Update To Follow

Wendy Booth, Director of Performance Assurance & Trust Secretary NLG(16)186 & Marcus Hassall, Director of Finance

13.8 Monthly Staffing Report, April 2016 To Follow

Dr Karen Dunderdale, Deputy Chief Executive & Mrs Jayne Adamson, NLG(16)187 Specialist HR Advisor

TGAC

13.9 TGAC Minutes, April 2016 To Follow

Wendy Booth, Director of Performance Assurance & Trust Secretary NLG(16)188

Audit Committee

13.11 Audit Committee Minutes, February 2016 To Follow

Marcus Hassall, Director of Finance NLG(16)189

IPCC

13.12 IPCC Minutes, March 2016 To Follow

Dr Karen Dunderdale, Deputy Chief Executive NLG(16)190

13.13 Trust Orthopaedic Surgical Site Infection Action Plan To Follow

Dr Karen Dunderdale, Deputy Chief Executive NLG(16)191

13.14 C.Difficile Action Plan To Follow

Dr Karen Dunderdale, Deputy Chief Executive NLG(16)192

13.15 MRSA Action Plan To Follow

Dr Karen Dunderdale, Deputy Chief Executive NLG(16)193

(7)

13.16 Charitable Funds Committee Minutes, February 2016 To Follow

References

Related documents

Methods: We investigated to what extent effortful control and attentional networks (i.e., Attention Network Task) explain concurrent depressive and anxious symptoms in

The Lead Independent Director will (i) preside at all meetings of the Board at which the Chairman of the Board is not present, including executive sessions, (ii) advise on

A total of 26 patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) were included in the study: 18 with +8, six with +11 and two with complex

Virtually all paid WiFi hotspots are public, relying on MAC address filtering to control access.. The MAC address filter is easily defeated, as

SYSTEMS AND EQUIPMENT 9 Generator Turbine Steam Condenser Electricity to Campus Steam to Campus Chilled Water to Campus Steam Turbine Condenser Chiller 42° F 4,160 volts 10 or 70 psi

Nomination & Remuneration Committee of the Company carried out an annual evaluation of performance of the Board and each Director on Board of the Company and Committees during

the supervisory Board received the audited and certified financial statements of Deutsche Beteiligungs aG for the year ended 30 september 2015 and the combined management report

The simplest way to address this problem is to base Medicare eligibility on the SSDI claim allowance month (rather than the entry month), thereby eliminating the need for